Carvedilol as a potential novel agent for the treatment of Alzheimer's disease

@article{Wang2011CarvedilolAA,
  title={Carvedilol as a potential novel agent for the treatment of Alzheimer's disease},
  author={Jun Wang and Kenjiro Ono and Dara L. Dickstein and Isabel Arrieta-Cruz and Wei Zhao and Xianjuan Qian and Ashley Lamparello and Rakesh Subnani and Mario Ferruzzi and Constantine Pavlides and Lap Ho and Patrick R. Hof and David B Teplow and Giulio Maria Pasinetti},
  journal={Neurobiology of Aging},
  year={2011},
  volume={32},
  pages={2321.e1-2321.e12}
}
Oligomeric β-amyloid (Aβ) has recently been linked to synaptic plasticity deficits, which play a major role in progressive cognitive decline in Alzheimer's disease (AD). Here we present evidence that chronic oral administration of carvedilol, a nonselective β-adrenergic receptor blocker, significantly attenuates brain oligomeric β-amyloid content and cognitive deterioration in 2 independent AD mouse models. We found that carvedilol treatment significantly improved neuronal transmission, and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 63 references

Amyloid beta protein dimers isolated directly from Alzheimer ’ s brains impair synaptic plasticity and memory

  • C. M. Regan, D. M. Walsh, B. L. Sabatini, D. J. Selkoe
  • Nat . Med .
  • 2008

Similar Papers

Loading similar papers…